{"nctId":"NCT00718237","briefTitle":"Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)","startDateStruct":{"date":"2008-08"},"conditions":["Rotavirus","Gastroenteritis"],"count":762,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Biological: Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™)"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Biological: Comparator: Comparator: Placebo (unspecified)"]}],"interventions":[{"name":"Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™)","otherNames":["RotaTeq™","V260"]},{"name":"Comparator: Comparator: Placebo (unspecified)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Healthy Japanese Infants, 6 Weeks Through 12 Weeks Of Age\n\nExclusion Criteria:\n\n* History Of Known Prior Rotavirus Gastroenteritis\n* Subjects Who Are Concurrently Participating In Or Are Anticipated To Participate In Other Studies Of Investigational Products At Any Time During The Study Period","healthyVolunteers":true,"sex":"ALL","minimumAge":"6 Weeks","maximumAge":"12 Weeks","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"SECONDARY","title":"Number of Participants With Moderate to Severe Rotavirus Gastroenteritis Caused by Rotavirus Serotypes G1, G2, G3, G4 and G-serotypes Associated With Serotype P1A","description":"Moderate to severe cases of rotavirus gastroenteritis caused by G1, G2, G3, G4 or G-serotypes associated with serotype P1A occurring at least 14 days postdose 3 in the per-protocol population using per-protocol case definition. Severity score was calculated based on frequency and duration of diarrhea, vomiting, elevated temperature, and behavioral changes. Score of \\>8 and \\<=16 was considered moderate, and \\>16 was considered severe.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"25","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Rotavirus Gastroenteritis of Any Severity Caused by Rotavirus Serotypes G1, G2, G3, G4 and G-serotypes Associated With Serotype P1A","description":"Any severity cases of rotavirus gastroenteritis caused by G1, G2, G3, G4 or G-serotypes associated with serotype P1A occurring at least 14 days postdose 3 in the per-protocol population using per-protocol case definition","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"27","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Severe Rotavirus Gastroenteritis Caused by Rotavirus Serotypes G1, G2, G3, G4 and G-serotypes Associated With Serotype P1A","description":"Severe cases of rotavirus gastroenteritis caused by G1, G2, G3, G4 or G-serotypes associated with serotype P1A occurring at least 14 days postdose 3 in the per-protocol population using per-protocol case definition. Severity score was calculated based on frequency and duration of diarrhea, vomiting, elevated temperature, and behavioral changes. Score of \\>8 and \\<=16 was considered moderate, and \\>16 was considered severe.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":7,"n":380},"commonTop":["Diarrhoea","Nasopharyngitis","Vomiting","Pyrexia","Upper respiratory tract inflammation"]}}}